Business Segments · Depreciation
Reportable Segment — Depreciation
Insmed Reportable Segment — Depreciation decreased by 19.0% to $2.93M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.8%, from $1.88M to $2.93M. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Depreciation shows an upward trend with a 25.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
How to read this metric
Stable levels indicate consistent investment in physical infrastructure.
Detailed definition
This represents the systematic allocation of the cost of tangible assets over their useful lives within the segment. It...
Peer comparison
Standard accounting practice for all capital-intensive industries.
Metric ID:
insm_segment_reportable_segment_depreciationHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.32M | $1.32M | $1.32M | $1.32M | $1.38M | $1.38M | $1.38M | $1.38M | $1.59M | $1.44M | $1.46M | $1.48M | $1.88M | $2.48M | $2.46M | $3.62M | $2.93M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +4.7% | +0.0% | +0.0% | +0.0% | +14.9% | -9.6% | +1.6% | +1.3% | +27.4% | +31.9% | -1.0% | +47.4% | -19.0% |
| YoY Change | — | — | — | — | +4.7% | +4.7% | +4.7% | +4.7% | +14.9% | +3.9% | +5.6% | +7.0% | +18.6% | +73.0% | +68.5% | +145.2% | +55.8% |
Range$1.32M – $3.62M
CAGR+22.1%
Avg YoY Growth+31.6%
Median YoY Growth+7.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Insmed's reportable segment — depreciation?
- Insmed (INSM) reported reportable segment — depreciation of $2.93M in Q1 2026.
- How has Insmed's reportable segment — depreciation changed year-over-year?
- Insmed's reportable segment — depreciation increased by 55.8% year-over-year, from $1.88M to $2.93M.
- What is the long-term trend for Insmed's reportable segment — depreciation?
- Over 3 years (2022 to 2025), Insmed's reportable segment — depreciation has grown at a 25.6% compound annual growth rate (CAGR), from $5.28M to $10.45M.
- What does reportable segment — depreciation mean?
- The non-cash expense representing the aging of physical assets used in the business.